Cargando…

Comparison of 10-Day Course of Triple Therapy Versus 14-Day Course for Eradication of Helicobacter pylori Infection in an Indonesian Population: Double-Blinded Randomized Clinical Trial

OBJECTIVE: The aim of this study was to compare the effectiveness of 10-day course of triple therapy versus a 14-day course in the treatment of H.pylori infection in an Indonesian population. METHODS: A double-blinded randomized clinical trial was included patients, Indonesian population, with H.pyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Herardi, Ryan, Syam, Ari Fahrial, Simadibrata, Marcellus, Setiati, Siti, Darnindro, Nikko, Abdullah, Murdani, Makmun, Dadang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294036/ https://www.ncbi.nlm.nih.gov/pubmed/31983158 http://dx.doi.org/10.31557/APJCP.2020.21.1.19

Ejemplares similares

The Role of EUS-BD in the Management of Malignant Biliary Obstruction: The Indonesian Perspective
por: Makmun, Dadang, et al.
Publicado: (2017)

Role of interventional endoscopic ultrasound in a developing country
por: Maulahela, Hasan, et al.
Publicado: (2023)

Prevalence and Risk Factors for Helicobacter Pylori Infection among Healthy Inhabitants in Northern Jakarta, Indonesia
por: Goto, Yasuyuki, et al.
Publicado: (2016)

Ramadan Fasting Decreases Body Fat but Not Protein Mass
por: Fahrial Syam, Ari, et al.
Publicado: (2016)

Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance
por: Miftahussurur, Muhammad, et al.
Publicado: (2019)

Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report
por: Syam, Ari Fahrial, et al.
Publicado: (2023)

Validation of Urine Test for Detection of Helicobacter pylori Infection in Indonesian Population
por: Syam, Ari Fahrial, et al.
Publicado: (2015)

Factors associated with health-related quality of life in patients with functional dyspepsia
por: Hantoro, Ibnu Fajariyadi, et al.
Publicado: (2018)

Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication
por: Eisig, Jaime N, et al.
Publicado: (2009)

The Value of Caspase-3 after the Application of Annona muricata Leaf Extract in COLO-205 Colorectal Cancer Cell Line
por: Abdullah, Murdani, et al.
Publicado: (2017)

Helicobacter pylori virulence genes in the five largest islands of Indonesia
por: Miftahussurur, Muhammad, et al.
Publicado: (2015)

Colorectal cancer patients in a tertiary hospital in Indonesia: Prevalence of the younger population and associated factors
por: Makmun, Dadang, et al.
Publicado: (2021)

Helicobacter pylori in the Indonesian Malay’s descendants might be imported from other ethnicities
por: Syam, Ari Fahrial, et al.
Publicado: (2021)

Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study
por: Syam, Ari Fahrial, et al.
Publicado: (2015)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
por: Azab, Eman T., et al.
Publicado: (2022)

Role of glycodeoxycholic acid to induce acute pancreatitis in Macaca nemestrina
por: Fauzi, Achmad, et al.
Publicado: (2022)

Evaluation of Helicobacter pylori eradication on the course of childhood nephrotic syndrome and its response to treatment
por: Bazmamoun, Hassan, et al.
Publicado: (2021)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
por: Tai, Wei-Chen, et al.
Publicado: (2013)

A Comparison between 10-day and 12-day Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Bari, Zohreh, et al.
Publicado: (2020)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

A comparison of efficacy and safety of potassium‐competitive acid blocker and proton pump inhibitor in gastric acid‐related diseases: A systematic review and meta‐analysis
por: Simadibrata, Daniel Martin, et al.
Publicado: (2022)

Sensitivity and Specificity of Magnetic Resonance Cholangiopancreatography versus Endoscopic Ultrasonography against Endoscopic Retrograde Cholangiopancreatography in Diagnosing Choledocholithiasis: The Indonesian Experience
por: Makmun, Dadang, et al.
Publicado: (2017)

Comparative Efficacy of 14-Day Tegoprazan-Based Triple vs. 10-Day Tegoprazan-Based Concomitant Therapy for Helicobacter pylori Eradication
por: Park, Chan Hyuk, et al.
Publicado: (2022)

Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection
por: Lee, Seong tae, et al.
Publicado: (2015)

Diagnostic Value of (14)C Urea Breath Test for Helicobacter pylori Detection Compared by Histopathology in Indonesian Dyspeptic Patients
por: Miftahussurur, Muhammad, et al.
Publicado: (2021)

Seven-day genotypic resistance-guided triple Helicobacter pylori eradication therapy can be highly effective
por: Papastergiou, Vasilios, et al.
Publicado: (2018)

Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication
por: Kwon, Yong Hwan, et al.
Publicado: (2023)

Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients
por: Arama, Stefan Sorin, et al.
Publicado: (2016)

Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: a randomised trial
por: Liou, Jyh-Ming, et al.
Publicado: (2016)

Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
por: Hajiani, Eskandar, et al.
Publicado: (2018)

Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations
por: Miftahussurur, Muhammad, et al.
Publicado: (2016)

Survival, stent patency, and cost‐effectiveness of plastic biliary stent versus metal biliary stent for palliation in malignant biliary obstruction in a developing country tertiary hospital
por: Farani, Muthia, et al.
Publicado: (2021)

7-Day Nonbismuth-Containing Concomitant Therapy Achieves a High Eradication Rate for Helicobacter pylori in Taiwan
por: Kao, Sung-Shuo, et al.
Publicado: (2012)

Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
por: Seyyedmajidi, Mohammadreza, et al.
Publicado: (2016)

Helicobacter pylori: Eradication or Preservation
por: Sachs, George, et al.
Publicado: (2012)

Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Talebi Bezmin Abadi, Amin
Publicado: (2016)

Efficacy and safety of 7 days versus 10 days triple therapy based on levofloxacin-dexlansoprazole for eradication of Helicobacter pylori: A pilot randomized trial
por: Elkhodary, Noha Mahmoud, et al.
Publicado: (2020)

Differences in the Insulin Resistance Levels Measured by HOMA-IR between Patients with Erosive and Non-Erosive Gastroesophageal Reflux Disease
por: Budiyani, Laras, et al.
Publicado: (2017)

Response to: Comment on “Efficacy of 7-Day and 14-Day Triple Therapy Regimens for the Eradication of Helicobacter pylori: A Comparative Study in a Cohort of Romanian Patients”
por: Ribaldone, Davide Giuseppe, et al.
Publicado: (2016)

Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection
por: Chen, Ming-Cheh, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ha35tub304p7u5b8mbtqb8tjdk